Politics | Trump Politics

Trump signs executive order to lower drug prices in fight against Big Pharma

The new order follows a series of four orders President Trump signed in July that similarly lowered prices of prescription drugs.

Health & Fitness | Health

Drug Prices Climb by 5.8% on Average, Less Than Last Year - WSJ

Pharmaceutical companies started 2020 by raising the prices of hundreds of drugs, according to a new analysis, though the average increase of 5.8% was lower than a year earlier amid growing scrutiny from patients, lawmakers and health plans.

Health & Fitness | Health

Drug Prices Index Falls Fastest Since 1960s Because of Trump, His Economic Advisers Say

The consumer price index for prescription drugs has fallen 2.3 percent from its peak in June 2018 through ...

Health & Fitness | Health

Judge rules against Trump on drug pricing disclosures | TheHill

A federal judge on Monday sided with a coalition of drug companies and blocked the Trump administration from implementing a policy that would require prescription drug manufacturers to disclose list prices in TV ads.

he is trying

Health & Fitness | Health

Trump 'favored-nation' drug pricing order could hammer profits | Fox Business

The move could force drugmakers to offer treatments in the U.S. at the lowest cost offered elsewhere in the world.

great idea

Politics | Trump Politics

Trump Vows to Bring US Drug Prices in Line With Other Countries, End 'Global Freeloading'

WASHINGTON—Speaking at the Department of Health and Human Services (HHS) on Oct. 25, President Donald Trump vowed to take on the “global freeloading” that makes drug prices higher in the United States than other developed nations. He announ

Nice to see an administration doing real studies that are unbiased and favor the American economy rather than relying on political favors. Drug prices should be low in the U.S. and Americans should not be penalized for their advancements giving benefits to others before themselves.

Health & Fitness | Health

President Trump Can End Drug Shortages, Reduce Prices By Promoting Competition | Investor's Business Daily

A new study by the Schaeffer Center for Health Policy at USC highlights the need for decisive action by the president, Congress, and federal anti-trust regulators to curb abuses by medical market middlemen that are driving up prices, causing drug shortage